The Metabolic Syndrome

Dr. Ashfaq ul Hassan; Dr. Shazia Nazir

Authors

Dr. Ashfaq ul Hassan
Dr. Shazia Nazir

Keywords:

diabetes, insulin, hypertension, obesity, resistance, panel, metabolic, lipoprotein

Abstract

The world population is noting an increasing trend towards development of particular diseases like Obesity, hypertension, diabetes mellitus. Some of them are turning into modern epidemics. These diseases can occur in isolation. Recent trends suggest the interlink age of the disease patterns leading to development of syndromes. One such syndrome is the Metabolic Syndrome. The Metabo1ic Syndrome is one of the major public health issues of this century. It is constellation of physical conditions and metabolic abnormalities commonly found in association with increased risk for development of Type 2 diabetes mellitus , Cardiovascular disease and other medical conditions. The article Deals with the Medical and Biochemical events occurring as a result of this developing medical Illness.

Downloads

How to Cite

The Metabolic Syndrome. (2015). Global Journal of Medical Research, 15(19), 1-3. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

Author Biography

Dr. Ashfaq ul Hassan

Dr. Ashfaq Ul Hassan is a medical researcher and academic affiliated with the Sher-i-Kashmir Institute of Medical Sciences (SKIMS) in Srinagar, India. His work spans anatomy, radiology, and neurosurgery, with published case studies on rare conditions such as internal carotid agenesis, median nerve schwannoma, and open lip schizencephaly with agenesis of the corpus callosum. He has also contributed to research on metabolic syndrome and trauma management. With over 85 publications and 216 citations, Dr. Hassan holds an h-index of 7 and an i10-index of 6, reflecting his ongoing impact in the medical field.

References

R. Kahn (2005) The metabolic syndrome: Time for a critical appraisal-joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. 28(9), 2289-2304.

Scott R Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus.

Eleazar Shafrir (1993) Animal Models of Syndrome X. 12, 165-181.

Peter Wilson, Ralph D'agostino, Helen Parise, Lisa Sullivan, James Meigs (2005) Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus. 112(20), 3066-3072. https://doi.org/10.1161/circulationaha.105.539528

Cameron AJ, Shaw JE, Zimmet PZ (2004) The metabolic syndrome: prevalence in worldwide populations. 33, 351-35.

DJ Nieves, Cnop M, Retzlaff B (2003) The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat. 52, 2-9.

Robert Ross, Jennifer Freeman, Robert Hudson, Ian Janssen (2002) Abdominal obesity, muscle composition, and insulin resistance in premenopausal women J Clin Endocrinol Metab. 87(11), 5044-5051. https://doi.org/10.1210/jc.2002-020570

Mark Danese, Paul Ladenson, Curtis Meinert, Neil Powe (2000) Effect of Thyroxine Therapy on Serum Lipoproteins in Patients with Mild Thyroid Failure: A Quantitative Review of the Literature*. 85(9), 2993-3001. https://doi.org/10.1210/jcem.85.9.6841

HN Ginsberg, LS Haung (2000) The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and Atherothrombosis. 7, 3235-3331.

Drayna D, Jamagin AS, Mclean J (1987) cloning and sequencing of the human cholesteryl ester transfer protein cDNA. 327(6123), 632-634. https://doi.org/10.1038/327632a0

Morton RE (1999) Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein. 10, 321-327.

Arai T, Yamashita S, Hirano K (1994) Increased plasma cholesteryl ester transfer protein in obese subjects: a possible mechanism for the reduction of serum HDL cholesterol levels in obesity. 14, 1129-1136.

Reilly MP, Rader DJ (2003) The metabolic syndrome; more than the sum of its parts. 108, 1546-1551.

Wilson PW, Grundy SM (2003) The metabolic syndrome: practical guide to origins and treatment: part I. 108, 1422-1424.

P. Barter, K-A Rye (1996) High density lipoproteins and coronary heart disease. 121(1), 1-12. https://doi.org/10.1016/0021-9150(95)05675-0

Kannel Wilson PW, H. Silbershatz (1999) Clustering of Metabolic Factors and Coronary Heart Disease. 159(10), 1104. https://doi.org/10.1001/archinte.159.10.1104

Yip J, Facchini GM (1998) Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease. 83, 2773-2776.